Migraine Drug Developer Biohaven Is Said to Explore Sale

(Bloomberg) -- Biohaven Pharmaceutical Holding Co., a developer of migraine treatments, is exploring options including a possible sale of the company after attracting interest from potential bidder...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.